Cobas Liat Nucleic Acid Test Influenza A+B Respiratory Syncytial Virus (RSV) For Cobas Liat Automated PCR Analyzer, 20 Tests **Requires Refrigeration*

The Cobas Liat Nucleic Acid Test Influenza A+B Respiratory Syncytial Virus (RSV) is a diagnostic test used to detect and differentiate between influenza virus type A and type B, as well as respiratory syncytial virus (RSV). The test is performed on the Cobas Liat Automated PCR Analyzer, a fully automated system that utilizes polymerase chain reaction (PCR) technology to amplify and detect viral genetic material in respiratory specimens. This test is intended for use in the rapid and accurate diagnosis of influenza and RSV infections, and can provide results in under 20 minutes. It is suitable for use in point-of-care settings such as hospitals, clinics, and physicians' offices.

Cobas Liat Nucleic Acid Test Influenza A / B, Respiratory Syncytial Virus (RSV) For Cobas Liat® Automated PCR Analyzer 20 Tests. Automated multiplex real-time RT-PCR assay for the rapid in vitro qualitative detection and discrimination of Influenza A and B virus and RSV RNA in nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.

Note: Non-Returnable Item

**Requires Refrigeration

• Testing accuracy with RT-PCR technology
• Definitive results with no need for interpretation or confirmation
• Fast, easy operation
• Three easy steps
• Results in 20 minutes

• The cobas® Influenza A/B & RSV test uses real-time PCR (polymerase chain reaction) technology to detect and differentiate influenza A virus RNA, influenza B virus RNA and respiratory syncytial virus (RSV) RNA in about 20 minutes
• It targets well-conserved regions of influenza A, influenza B and RSV RNA to provide broad strain coverage and has been validated on over 40 commonly found strains of influenza A and B and seven commonly found strains of RSV

Accuracy: Influenza A: Positive Agreement 98.4%, Negative Agreement 96.5%. Influenza B: Positive Agreement 97.9%, Negative Agreement 99.4%. RSV: Positive Agreement 97.8%, Negative Agreement 98.4%